Yahoo Finance • 8 hours ago
Immutep Limited Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this is above the amount needed to conduct the futility analysis Over 100 clinical sites across 24 countries now acti... Full story
Yahoo Finance • 9 hours ago
[Centers for disease control and prevention sign] sshepard The Centers for Disease Control and Prevention (CDC) has postponed an October meeting of its Advisory Committee on Immunization Practices (ACIP), an expert panel whose views are c... Full story
Yahoo Finance • 9 hours ago
RAHWAY, N.J., October 09, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European... Full story
Yahoo Finance • 11 hours ago
Company Logo The bispecific antibodies market presents key opportunities in oncology, autoimmune, and infectious diseases, driven by rapid technological advancements and strategic collaborations. Regional manufacturing and diverse supplie... Full story
Yahoo Finance • yesterday
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Merck (MRK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Merck between February 3, 2022, t... Full story
Yahoo Finance • yesterday
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Best Non-Tech Stocks to Buy According to Reddit, supported by hedge fund interest.Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA);... Full story
Yahoo Finance • yesterday
We recently published Top 10 Trending Stocks as Famous Billionaire Predicts Massive AI Stock Rally Before Bubble Burst. Merck & Co., Inc. (NYSE:MRK) is one of the trending stocks. Carter Worth from Worth Charting said in a latest program... Full story
Yahoo Finance • yesterday
MUMBAI, India, Oct. 8, 2025 /PRNewswire/ -- The Indo-German Chamber of Commerce hosted its 69th Annual General Meeting on 24th September 2025 in Mumbai. As a member firm, Transjovan Capital's Managing Partner, Gaurav Asthana attended the a... Full story
Yahoo Finance • yesterday
Company Logo The global cutaneous squamous cell carcinoma market is set for robust growth, driven by rising skin cancer incidences and treatment advancements. This market expansion is fueled by increased UV exposure, environmental factors... Full story
Yahoo Finance • yesterday
Merck (MRK) has recently wrapped up another month of trading, sparking renewed discussion about its longer-term performance. Investors are evaluating the stock’s modest month climb and considering how it compares to the company’s broader t... Full story
Yahoo Finance • 2 days ago
Lab equipment scheduling platform supporting pharma and life sciences R&D organisations’ AI journey amidst industry upheaval LONDON, October 08, 2025--(BUSINESS WIRE)--Clustermarket, the lab equipment scheduling platform, has today announ... Full story
Yahoo Finance • 2 days ago
LUND, SE / ACCESS Newswire / October 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) (STO:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies... Full story
Yahoo Finance • 2 days ago
Merck & Co., Inc. (NYSE:MRK) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now.Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks An American multinational pharmaceutical company, Merc... Full story
Yahoo Finance • 2 days ago
Company's leading hardware-agnostic fleet orchestration software platform delivers operational savings and worker safety to its customers DARMSTADT, Germany, Oct. 7, 2025 /PRNewswire/ -- Energy Robotics, the leading AI software platform f... Full story
Yahoo Finance • 3 days ago
Verona Pharma plc LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on Ju... Full story
Yahoo Finance • 3 days ago
Trying to decide what to do with Merck’s stock right now? You are definitely not alone. After all, just in the past week, Merck’s shares have jumped 13.5%, a rapid turnaround when you consider the stock is still down 10.1% for the year and... Full story
Yahoo Finance • 4 days ago
[Pfizer HQ in New York City] georgeclerk What's the most attractive Big Pharma stock right now? We asked Seeking Alpha analysts The Value Portfolio [https://seekingalpha.com/author/the-value-portfolio] and ALLKA Research [https://seeking... Full story
Yahoo Finance • 5 days ago
Merck & Co., Inc. (NYSE:MRK) is one of the Best and Cheap Stocks to Buy Right Now. On September 30, Courtney Breen from Bernstein reiterated a Hold rating on Merck & Co., Inc. (NYSE:MRK) without disclosing any price target. Merck & Co., I... Full story
Yahoo Finance • 5 days ago
Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer put under the microscope. Cramer discussed it while highlighting the performance of healthcare stocks. He said: “Some of these healthcare stocks seem played out already to you... Full story
Yahoo Finance • 5 days ago
[President Trump Delivers An Announcement From The Oval Office] Win McNamee/Getty Images News The world’s biggest pharma companies recorded their best weekly performance in years on Friday after Pfizer (NYSE:PFE [https://seekingalpha.com/... Full story